29354 Federal Register / Vol. 87, No. 93 / Friday, May 13, 2022 / Notices 

3. Questions on systems matters may 

be directed to: Paul Gettys, Deputy 

Director, Division of Grants 

Management, Indian Health Service, 

Division of Grants Management, 5600 

Fishers Lane, Mail Stop: 09E70, 

Rockville, MD 20857, Phone: (301) 443– 

2114; or the DGM main line (301) 443– 

5204, Email: Paul.Gettys@ihs.gov. 

VIII. Other Information 

The Public Health Service strongly 

encourages all grant, cooperative 

agreement, and contract recipients to 

provide a smoke-free workplace and 

promote the non-use of all tobacco 

products. In addition, Public Law 103– 

227, the Pro-Children Act of 1994, 

prohibits smoking in certain facilities 

(or in some cases, any portion of the 

facility) in which regular or routine 

education, library, day care, health care, 

or early childhood development 

services are provided to children. This 

is consistent with the HHS mission to 

protect and advance the physical and 

mental health of the American people. 

Elizabeth A. Fowler, 

Acting Director, Indian Health Service. 

[FR Doc. 2022–10241 Filed 5–12–22; 8:45 am] 

BILLING CODE 4165–16–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Notice of Diabetes Mellitus Interagency 

Coordinating Committee Meeting 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: The Diabetes Mellitus 

Interagency Coordinating Committee 

(DMICC) will hold a meeting on June 16, 

2022. The topic for this meeting will be 

‘‘National Clinical Care Commission 

Report Perspectives from Federal 

Partners to Prevent and Control Diabetes 

and its Complications’’. The meeting is 

open to the public. 

DATES: The meeting will be held on 

June, 16 2022 from 12:00 p.m. to 4:00 

p.m. EDT. 

ADDRESSES: The meeting will be held in 

person at NIH Campus, Building 31, 

floor 6C conference room F & G and via 

the Zoom online video conferencing 

platform. For details, and to register, 

please contact dmicc@mail.nih.gov. 

FOR FURTHER INFORMATION CONTACT: For 

further information concerning this 

meeting, including a draft agenda, 

which will be posted when available, 

see the DMICC website, 

www.diabetescommittee.gov, or contact 

Dr. William Cefalu, Executive Secretary 

of the Diabetes Mellitus Interagency 

Coordinating Committee, National 

Institute of Diabetes and Digestive and 

Kidney Diseases, 6707 Democracy 

Boulevard, Democracy 2, Room 6037, 

Bethesda, MD 20892, telephone: 301– 

435–1011; email: dmicc@mail.nih.gov. 

SUPPLEMENTARY INFORMATION: In 

accordance with 42 U.S. Code 285c–3, 

the DMICC, chaired by the National 

Institute of Diabetes and Digestive and 

Kidney Diseases (NIDDK) comprising 

members of the Department of Health 

and Human Services and other federal 

agencies that support diabetes-related 

activities, facilitates cooperation, 

communication, and collaboration on 

diabetes among government entities. 

DMICC meetings, held several times a 

year, provide an opportunity for 

Committee members to learn about and 

discuss current and future diabetes 

programs in DMICC member 

organizations and to identify 

opportunities for collaboration. The 

June 16, 2022 DMICC meeting will focus 

on ‘‘National Clinical Care Commission 

Report Perspectives from Federal 

Partners to Prevent and Control Diabetes 

and its Complications.’’ 

Any member of the public interested 

in presenting oral comments to the 

Committee should notify the contact 

person listed on this notice at least 5 

days in advance of the meeting. 

Interested individuals and 

representatives or organizations should 

submit a letter of intent, a brief 

description of the organization 

represented, and a written copy of their 

oral presentation in advance of the 

meeting. Only one representative of an 

organization will be allowed to present; 

oral comments and presentations will be 

limited to a maximum of 5 minutes. 

Printed and electronic copies are 

requested for the record. In addition, 

any interested person may file written 

comments with the Committee by 

forwarding their statement to the 

contact person listed on this notice. The 

statement should include the name, 

address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Because of time constraints for the 

meeting, oral comments will be allowed 

on a first-come, first-serve basis. 

Members of the public who would 

like to receive email notification about 

future DMICC meetings should register 

for the listserv available on the DMICC 

website, www.diabetescommittee.gov. 

William T. Cefalu, 

Director Division of Diabetes, Endocrinology, 

and Metabolic Diseases, National Institute of 

Diabetes and Digestive and Kidney Diseases, 

and Metabolic Diseases, National Institutes 

of Health. 

[FR Doc. 2022–10398 Filed 5–12–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institutes of Health Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the Advisory Committee to 

the Director, National Institutes of 

Health. 

These meetings will be held as virtual 

meetings and are open to the public. 

Individuals who plan to view the virtual 

meeting and need special assistance or 

other reasonable accommodations to 

view the meeting, should notify the 

Contact Person listed below in advance 

of the meeting. The meetings will be 

videocast and can be accessed from the 

NIH Videocasting and Podcasting 

website (http://videocast.nih.gov/). 

Name of Committee: Advisory Committee 

to the Director; National Institutes of Health. 

Date: June 9, 2022. 

Time: 10:00 a.m. to 4:45 p.m. 

Agenda: NIH Acting Director’s Report, 

Updates on ARPA–H and COVID–19, ACD 

Working Group Updates, Other Business of 

the Committee. 

Place: National Institutes of Health, 

Building 1, One Center Drive, Bethesda, MD 

20892 (Virtual Meeting). 

Name of Committee: Advisory Committee 

to the Director; National Institutes of Health. 

Date: June 10, 2022. 

Time: 10:00 a.m. to 2:45 p.m. 

Agenda: Diversity, Equity, Inclusion and 

Accessibility (DEIA) Strategic Plan, UNITE, 

Other Business of the Committee. 

Place: National Institutes of Health, 

Building 1, One Center Drive, Bethesda, MD 

20892 (Virtual Meeting). 

Contact Person: Cyndi Burrus-Shaw, Staff 

Assistant, National Institutes of Health, 

Office of the Director, One Center Drive, 

Building 1, Room 126, Bethesda, MD 20892, 

301–496–2433, shawcy@od.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 87, No. 93 / Friday, May 13, 2022 / Notices 29355 

Information is also available on the 

Institute’s/Center’s home page: http://

acd.od.nih.gov, where an agenda and any 

additional information for the meeting will 

be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.14, Intramural Research 

Training Award; 93.22, Clinical Research 

Loan Repayment Program for Individuals 

from Disadvantaged Backgrounds; 93.232, 

Loan Repayment Program for Research 

Generally; 93.39, Academic Research 

Enhancement Award; 93.936, NIH Acquired 

Immunodeficiency Syndrome Research Loan 

Repayment Program; 93.187, Undergraduate 

Scholarship Program for Individuals from 

Disadvantaged Backgrounds, National 

Institutes of Health, HHS) 

Dated: May 10, 2022. 

David W. Freeman, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–10360 Filed 5–12–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Healthcare Delivery 

and Methodologies Integrated Review Group; 

Clinical Informatics and Digital Health Study 

Section. 

Date: June 8–9, 2022. 

Time: 9:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Paul Hewett-Marx, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institute of 

Health, 6701 Rockledge Drive, Room, 

Bethesda, MD 20892, (240) 672–8946, 

hewettmarxpn@csr.nih.gov. 

Name of Committee: Genes, Genomes, and 

Genetics Integrated Review Group; 

Prokaryotic Cell and Molecular Biology 

Study Section. 

Date: June 14–15, 2022. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Rebecca C. Burgess, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, 6701 Rockledge Drive, 

Bethesda, MD 20892, (301) 480–8034, 

rebecca.burgess@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR Panel: 

International and Cooperative Projects. 

Date: June 15, 2022. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Seetha Bhagavan, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5194, 

MSC 7846, Bethesda, MD 20892, (301) 237– 

9838, bhagavas@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Training in 

Veterinary and Comparative Medicine. 

Date: June 15, 2022. 

Time: 11:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Marie-Jose Belanger, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Rm. 6188, 

MSC 7804, Bethesda, MD 20892, (301) 435– 

1267, belangerm@csr.nih.gov. 

Name of Committee: Digestive, Kidney and 

Urological Systems Integrated Review Group; 

Kidney and Urological Systems Function and 

Dysfunction Study Section. 

Date: June 16–17, 2022. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Ganesan Ramesh, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2182, 

MSC 7818, Bethesda, MD 20892, (301) 827– 

5467, ganesan.ramesh@nih.gov. 

Name of Committee: Integrative, 

Functional and Cognitive Neuroscience 

Integrated Review Group; Learning, Memory 

and Decision Neuroscience Study Section. 

Date: June 16–17, 2022. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Roger Janz, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 402–8515, janzr2@csr.nih.gov. 

Name of Committee: Cardiovascular and 

Respiratory Sciences Integrated Review 

Group; Clinical Integrative Cardiovascular 

and Hematological Sciences Study Section. 

Date: June 16–17, 2022. 

Time: 9:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Margaret Chandler, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4126, 

MSC 7814, Bethesda, MD 20892, (301) 435– 

1743, margaret.chandler@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: The Cancer Biotherapeutics 

Development (CBD). 

Date: June 16–17, 2022. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Laurie Ann Shuman Moss, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, 6701 Rockledge Drive, 

Bethesda, MD 20892, (301) 867–5309, 

laurie.shumanmoss@nih.gov. 

Name of Committee: Surgical Sciences, 

Biomedical Imaging and Bioengineering 

Integrated Review Group; Clinical 

Translational Imaging Science Study Section. 

Date: June 16–17, 2022. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Eleni Apostolos Liapi, MD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20817, (301) 867–5309, eleni.liapi@nih.gov. 

Name of Committee: Oncology 1-Basic 

Translational Integrated Review Group; 

Tumor Progression and Metastasis Study 

Section. 

Date: June 16–17, 2022. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Rolf Jakobi, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6187, 

MSC 7806, Bethesda, MD 20892, 301–495– 

1718, jakobir@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 


lotter on DSK11XQN23PROD with NOTICES1